INAFM1

Across TCGA pan-cancer cohorts, INAFM1 RNA is linked to patient survival in 28 of 34 cancer types, making it the most broadly survival-associated INAFM1 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher INAFM1 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated INAFM1 expression acts as an unfavorable survival marker, although some lineages such as CESC and CHOL show a favorable association.

KIRC, COAD, and ACC are the cancer types where INAFM1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	DFS	Tertile	All	0.748	0.877	<.001	125	view →
COAD	OS	Median	II,III,IV	0.710	0.852	.001	73	view →
ACC	DFS	Quartile	All	0.193	0.691	<.001	57	view →
LGG	DFS	Median	All	0.281	0.482	<.001	54	view →
READ	OS	Median	II,III,IV	0.440	0.804	<.001	37	view →
CESC	DFS	Quartile	III,IV	0.900	0.364	.002	28	view →
UCS	DFS	Median	IV	0.367	0.952	.001	24	view →
CHOL	OS	Median	III,IV	1.000	0.286	.008	21	view →
HNSC	DFS	Tertile	III,IV	0.419	0.286	.011	18	view →
MESO	OS	Median	All	0.315	0.656	.013	18	view →
PRAD	DFS	Median	All	0.697	0.877	<.001	18	view →
DLBC	DFS	Quartile	All	1.000	0.647	.013	14	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 28 lineages.

INAFM1–KIRC (DFS)

Open the KIRC breakdown →